Lv1
90 积分 2024-05-30 加入
Properties of Drug Linkers Affecting Hydrophobic Interaction Chromatography for Determining the Drug-to-Antibody Ratio of Antibody-Drug Conjugates
6小时前
已完结
Systematic development and optimization of a cIEF method for the charge variants analysis of moderately basic to basic monoclonal antibodies using the Analytical Quality by Design strategy
1天前
已完结
Impact of process impurities on developability assessments of complex antibody formats: the striking role of leachable copper
2天前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
8天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
8天前
已完结
Oxidation-Induced Destabilization of Model Antibody-Drug Conjugates
9天前
已完结
LC-MS in Drug Analysis
9天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
9天前
已完结
Regulatory Framework for the Manufacturing and Marketing of ADCs
12天前
已完结
Considerations for Antibody-Drug Conjugate Design: Stability and Formulation
12天前
已完结